Novartis Pharma AG has provided funding for the Zurich Heart House Postgraduate Course in Cardiometabolic Medicine 2025 as part of a sponsorship. Novartis has had no input into the content, organisation, conduct or outputs relating to the Event, except for the Novartis sponsored symposium.